therapy group:Reinfusion cell
Sponsors
Beijing Boren Hospital, Shanghai Zhaxin Integrated Traditional Chinese and Western Medicine Hospital, Dermatology Hospital of Southern Medical University
Conditions
Hematological malignanciesMalignant neoplasm of skinRefractory and relapsed acute T lymphocytic leukemiaRefractory/relapsed acute T lymphoblastic leukemia in children
Early Phase 1
A single-center, open, non-randomized, single-arm clinical trial of donor CD5-CAR T cells in the treatment of refractory/relapsed acute T lymphoblastic leukemia in children
RecruitingChiCTR2000039519
Start: 2020-10-29Updated: 2021-02-01
A single-center, open, non-randomized, single-arm clinical study of CD4-CART in the treatment of refractory and relapsed acute T lymphoblastic leukemia
RecruitingChiCTR2100042782
Start: 2021-01-26Updated: 2021-05-10
A clinical study on the therapeutic safety, tolerability, efficacy and pharmacokinetic characteristics of chimeric antigen receptor T cells in patients with hematological malignancies
RecruitingChiCTR2100043305
Start: 2021-03-01Updated: 2021-06-07
A single-arm, non-blind clinical study on the safety and efficacy of B7H3-CART in patients with B7H3-positive malignant skin tumors
RecruitingChiCTR2100044386
Start: 2020-09-17Updated: 2021-09-07